```html

X‑ray Induced Dermatitis

Overview

X‑ray induced dermatitis, also known as radiation dermatitis or radiodermatitis, is an acute or chronic inflammatory skin reaction that occurs after exposure to ionizing radiation from diagnostic or therapeutic X‑ray procedures. While low‑dose diagnostic imaging (e.g., chest X‑ray) rarely causes clinically evident skin changes, higher cumulative doses from fluoroscopy‑guided interventions, interventional radiology, or repeated CT scans can damage the epidermis and dermis, leading to dermatitis.

The condition most commonly affects adults undergoing repeated or prolonged procedures, such as cardiac catheterization patients, interventional radiologists, orthopedic surgeons, and radiation oncology staff. Pediatric patients who receive multiple CT scans are also at risk, although their skin is generally more radiosensitive, prompting stricter dose‑monitoring protocols.

Prevalence – Epidemiological data are limited because many cases are mild and under‑reported. A 2021 systematic review of fluoroscopy‑guided procedures found that approximately 2–6 % of patients developed grade 2 or higher radiation dermatitis, with higher rates (up to 14 %) in complex, lengthy interventions such as endovascular aneurysm repair.<sup>[1] Mayo Clinic</sup> Occupational radiation dermatitis among interventional staff occurs in 5–10 % of workers despite protective measures.<sup>[2] CDC</sup>

Symptoms

Symptoms usually appear within days to weeks after the radiation exposure, depending on dose intensity and individual susceptibility. They follow a predictable progression that can be graded using the Common Terminology Criteria for Adverse Events (CTCAE) scale.

Early (Grade 1–2) Manifestations

• Erythema: Pink to red discoloration, similar to a mild sunburn.
• Warmth: A sensation of heat over the affected area.
• Itching (pruritus): Often mild to moderate.
• Tenderness: Discomfort when the skin is touched.

Intermediate (Grade 3) Manifestations

• Moist desquamation: Peeling skin that becomes weepy or oozes fluid.
• Edema: Swelling of the skin and subcutaneous tissue.
• Painful ulceration: Open sores that may bleed.

Severe (Grade 4–5) Manifestations

• Necrosis: Full‑thickness tissue death, often with black eschar.
• Chronic ulceration: Non‑healing wounds that may persist for months.
• Secondary infection: Pus, foul odor, fever, or cellulitis.
• Fibrosis & contracture: Thickened, stiff skin that restricts movement.

Causes and Risk Factors

Radiation dermatitis results from ionizing radiation damaging DNA, cell membranes, and micro‑vascular structures in the skin. The severity depends on the total absorbed dose (measured in Gray, Gy), dose‑rate, fractionation, and the area of skin exposed.

Primary Causes

• Therapeutic ionizing radiation: External beam radiation therapy (EBRT) for cancer.
• Interventional radiology / fluoroscopy: Prolonged procedures (e.g., angiography, embolization).
• Repeated CT imaging: Particularly when scans are performed in the same region.
• Industrial X‑ray exposure: Non‑medical settings with inadequate shielding.

Risk Factors

• Cumulative dose: Doses >2 Gy to skin increase risk of moderate‑to‑severe dermatitis.
• Large field size: Larger surface area exposed distributes heat, causing more damage.
• Short interval between exposures: Reduces time for skin repair.
• Patient factors: Age >60, thin skin, diabetes, connective‑tissue disorders, poor nutrition, smoking.
• Medication interactions: Chemotherapy agents (e.g., 5‑FU, doxorubicin) and certain antibiotics (e.g., dapsone) can sensitize skin.
• Occupational exposure: Inadequate protective lead aprons or shielding for healthcare workers.

Diagnosis

Diagnosis is primarily clinical, supported by a careful history of radiation exposure and targeted examinations.

Clinical Evaluation

• Inspection of the skin’s color, texture, and any ulceration.
• Assessment of pain, itching, and functional limitation.
• Documentation of radiation parameters (dose, field size, duration).

Adjunctive Tests

• Skin biopsy: Reserved for atypical presentations to rule out infection or malignancy.
• Water‑soluble dye test (e.g., Patent Blue V): Helps map vascular compromise in severe cases.
• Imaging: Ultrasound or MRI may be used to evaluate deep tissue involvement when fibrosis is suspected.
• Laboratory studies: CBC, CRP, and wound cultures if infection is suspected.

Treatment Options

Treatment goals are to relieve symptoms, promote healing, prevent infection, and minimize scar formation. Management is staged according to severity.

Grade 1–2 (Mild)

• Topical corticosteroids: Low‑potency (hydrocortisone 1 %) for erythema and pruritus.
• Moisturizers / emollients: Petrolatum‑based ointments applied 2–3 times daily.
• Cool compresses: 10–15 minutes, 3–4 times/day to reduce warmth.
• Analgesia: Acetaminophen or ibuprofen for mild pain.

Grade 3 (Moderate)

• Mid‑potency steroids: Triamcinolone 0.1 % cream BID.
• Barrier dressings: Silicone or hydrocolloid pads to protect moist desquamation.
• Debridement: Gentle, atraumatic removal of necrotic tissue; performed by a wound‑care specialist.
• Systemic antibiotics: If secondary infection is confirmed (e.g., oral cephalexin).
• Pain control: Short‑course oral opioids (e.g., hydrocodone) if needed.

Grade 4–5 (Severe)

• Advanced wound care: Vacuum‑assisted closure (VAC) therapy, alginate or silver‑impregnated dressings.
• Surgical intervention: Flap or graft reconstruction for extensive necrosis.
• Hyperbaric oxygen therapy (HBOT): 2–3 sessions/week for 4–6 weeks can enhance angiogenesis.
• Systemic steroids: Short taper (e.g., prednisone 0.5 mg/kg) in refractory inflammatory cases, under specialist supervision.
• Infection management: IV antibiotics guided by culture results.

Adjunctive Measures

• Nutrition: Protein ≥ 1.2 g/kg/day, vitamin C, zinc supplementation to support healing.
• Smoking cessation: Improves microvascular flow.
• Physical therapy: Range‑of‑motion exercises to prevent contracture.

Living with X‑ray Induced Dermatitis

Patients can adopt daily habits that reduce discomfort and promote skin recovery.

Skin Care Routine

• Gentle, fragrance‑free cleanser; avoid scrubbing.
• Apply emollient immediately after bathing (the “seal‑in” method).
• Use non‑adhesive dressings; change dressings according to wound‑care provider instructions.
• Avoid tight clothing or friction over the affected area.

Lifestyle Adjustments

• Maintain a balanced diet rich in antioxidants (berries, leafy greens).
• Stay hydrated – 2–3 L of water per day.
• Engage in low‑impact aerobic activity (walking, swimming) unless limited by pain.
• Track radiation exposure logs if you undergo repeated procedures; share with your physician.

Psychosocial Support

Chronic skin changes can affect self‑image. Consider counseling, support groups, or referral to a psychologist experienced in patients with disfiguring skin conditions.

Prevention

Preventing radiation dermatitis hinges on minimizing unnecessary radiation and protecting the skin when exposure is unavoidable.

• Justify every X‑ray: Use evidence‑based guidelines (e.g., ALARA – “As Low As Reasonably Achievable”).
• Optimize technique: Collimate the beam, use pulsed fluoroscopy, and keep the distance between the X‑ray source and skin as great as possible.
• Shielding: Lead aprons, thyroid collars, and eye protection for patients; leaded gloves and aprons for staff.
• Skin dose monitoring: Real‑time dosimeters (e.g., skin dose mapping software) during long procedures.
• Pre‑procedure skin preparation: Apply a thin layer of barrier cream (e.g., Cavilon) on high‑dose entry sites.
• Limit repeat imaging: Consolidate multiple studies into a single, comprehensive scan when safe.
• Educate patients: Provide written instructions on skin care after any high‑dose procedure.

Complications

If not appropriately managed, radiation dermatitis can lead to serious sequelae.

• Infection: Cellulitis, abscess formation, or systemic sepsis.
• Chronic ulceration: May require long‑term wound‑care services.
• Fibrosis and contracture: Restricts joint movement, potentially necessitating surgical release.
• Radiation‑induced skin cancer: Although rare, long‑term mutagenic effects can increase basal cell carcinoma risk in the irradiated field.
• Pain syndromes: Neuropathic pain may persist after tissue healing.

When to Seek Emergency Care

For all other concerns, contact your primary care physician, dermatologist, or the radiation oncology team promptly. Early intervention improves outcomes and reduces the risk of permanent scarring.

References

1. Mayo Clinic. Radiation Dermatitis. Updated 2023. https://www.mayoclinic.org
2. Centers for Disease Control and Prevention (CDC). Radiation Safety for Health Care Workers. 2022. https://www.cdc.gov
3. American Society for Radiation Oncology (ASTRO). Management of Radiation Skin Reactions. 2021. https://www.astrobics.org
4. World Health Organization (WHO). Ionizing Radiation, Health Effects and Protective Measures. 2020. https://www.who.int
5. Cleveland Clinic. Radiation Dermatitis: Symptoms, Causes, and Treatment. 2022. https://my.clevelandclinic.org
6. National Institutes of Health (NIH). Radiation‑Induced Skin Toxicity. 2021. https://www.ncbi.nlm.nih.gov

```